Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
Abstract Introduction Biomarker testing is mandatory for the clinical management of patients with advanced non-small cell lung cancer (NSCLC). Myriads of technical platforms are now available for biomarker analysis with differences in terms of multiplexing capability, analytical sensitivity, and tur...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-01-01
|
Series: | Oncology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40487-023-00252-5 |